Clinical Trials Sponsored by Natera, Inc

Total 36289 results

Atea Pharmaceuticals, Inc.

Withdrawn

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Hepatitis C Virus Infection | Hepatitis C | Hepatitis C, Chronic | Chronic Hepatitis C | HCV Infection

Belgium
Atea Pharmaceuticals, Inc.

Completed

Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection

Hepatitis C Virus Infection | Hepatitis C | Hepatitis C, Chronic | Chronic Hepatitis C | HCV Infection

Belgium, Mauritius, Moldova, Republic of
Atea Pharmaceuticals, Inc.

Recruiting

Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir

Healthy Volunteer Study

United States
Atea Pharmaceuticals, Inc.

Recruiting

Study of AT-527 in Subjects With Normal and Impaired Renal Function

Renal Impairment | Healthy Volunteer

Canada
Atea Pharmaceuticals, Inc.

Completed

The Study of Bemnifosbuvir in Healthy Japanese Subjects

Healthy Volunteer Study

United States
Atea Pharmaceuticals, Inc.

Completed

Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir (AT-527)

Healthy Volunteer Study

Canada
Atea Pharmaceuticals, Inc.

Terminated

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting

COVID-19

United States, Argentina, Belgium, Brazil, Egypt, Moldova, Republic of, Romania, South Africa, Spain, Ukraine
Atea Pharmaceuticals, Inc.

Completed

Study of AT-527 in Healthy and HCV-Infected Subjects

Hepatitis C | Hepatitis C, Chronic | Chronic Hepatitis C

Belgium, Moldova, Republic of
Boston Medical Center
Entera Health, Inc

Completed

Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA

Pouchitis | Irritable Pouch Syndrome

United States
Natural Immunogenics Corp.
KGK Science Inc.

Completed

A Study Investigating the Safety and Efficacy of Bio-Active Silver Hydrosol™ in Providing Immune Support

Healthy

Canada
National University of Natural Medicine
Metagenics, Inc.

Completed

Influence of an Omega-3 SPM Supplement on Quality of Life

Chronic Pain

United States
NorthShore University HealthSystem
L-Nutra Inc

Not yet recruiting

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

Ovarian Cancer | Chemotherapeutic Toxicity

United States
Rutgers, The State University of New Jersey
Natera, Inc.; BioGene Pharmaceutical Ltd.

Recruiting

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

Carcinoma, Hepatocellular | Liver Cell Carcinoma

United States
Metagenics, Inc.
National University of Natural Medicine

Completed

Effect of UGIR in Adults With Compromised Gut Function and Malabsorption

Irritable Bowel Syndrome | Celiac Disease | Crohn Disease | Ulcerative Colitis
Cedars-Sinai Medical Center
Entera Health, Inc

Completed

Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth

Small Intestinal Bacterial Overgrowth | Diarrhea Predominant Irritable Bowel Syndrome

United States
Hypertension Institute, Nashville
L-Nutra Inc

Completed

Evaluation of a Fasting Mimicking Diet

Coronary Artery Disease

United States
Essentia Water, LLC
Health Onvector Inc.

Completed

Dehydration, Rehydration, and Blood Viscosity

Dehydration

United States
Galera Therapeutics, Inc.
M.D. Anderson Cancer Center

Completed

Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer

Pancreatic Cancer | Stereotactic Body Radiation Therapy

United States
Metagenics, Inc.
National University of Natural Medicine

Completed

Prospective Tolerability Assessment of a Probiotic Dietary Supplement

Healthy Adults

United States
Natural Immune Systems Inc
JBSL-USA Incorporated

Completed

Effects of NSK-SD (Nattokinase) on Blood Pressure

Hypertension
Galera Therapeutics, Inc.
INC Research Australia Pty Ltd; Nucleous Network

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers

Healthy Volunteer

Australia
Nara Organics
Paidion Research, Inc.

Completed

Growth and Safety Clinical Trial on a New Infant Formula.

Healthy Growth

United States
Medical University of South Carolina
Entera Health, Inc

Completed

Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD (SBI for COPD)

Advanced COPD (GOLD Stage 3 or 4) With Cachexia

United States
TruDiagnostic
L-Nutra Inc; Peak Human Labs

Active, not recruiting

The Impact of a Fast Diet and Calorie Mimetic Supplements on Epigenetic Aging

Aging

Canada
Assisting Nature

Recruiting

Invasive PGT-A Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

Infertility | Aneuploidy | Chromosome Abnormality

Greece
Assisting Nature

Recruiting

Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

Infertility | Aneuploidy | Chromosome Abnormality

Greece
Herbacure Natural

Completed

Improvement of Migraine Severity and Frequency With Migraineguard ™

Migraine | Headache

Canada
Assisting Nature

Unknown

Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.

Infertility | Premature Ovarian Failure

Greece
Assisting Nature

Unknown

The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate

Pregnancy, Ovarian

Greece
Anthera Pharmaceuticals

Completed

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States, Hungary, Israel, Poland, Spain, Canada, Czechia
Anthera Pharmaceuticals

Completed

SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (SIMPLICITY)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Anthera Pharmaceuticals

Withdrawn

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Systemic Lupus Erythematosus
Anthera Pharmaceuticals

Withdrawn

BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis (BIANCA-SC)

Microscopic Polyangiitis | Granulomatosis With Polyangiitis
Anthera Pharmaceuticals

Withdrawn

BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy

IgA Nephropathy
Anthera Pharmaceuticals

Terminated

Phase III ALTU-135 CP Safety Trial (DIGEST CP)

Exocrine Pancreatic Insufficiency

United States
Anthera Pharmaceuticals

Completed

Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency (DIGEST)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Anthera Pharmaceuticals

Completed

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus (PEARL-SC)

Systemic Lupus Erythematosus

United States, Argentina, Brazil, Chile, Colombia, Hong Kong, India, Mexico, Peru, Philippines, Taiwan
Anthera Pharmaceuticals

Completed

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease (PLASMA 2)

Coronary Artery Disease

United States
National University Hospital, Singapore
Natera, Inc.; The N.1 Institute for Health (N.1)

Recruiting

Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements

Solid Tumor

Singapore
Azienda Sanitaria Locale di Matera

Completed

Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV

Benign Paroxysmal Positional Vertigo (BPPV)

Italy
Nebraska Methodist Health System
Acera Surgical, Inc.

Terminated

Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site

Head and Neck Cancer

United States
Natural Cycles

Completed

NC Thermometer (Gen 3) ISO 80601-2-56 Validation

Healthy | Fever | Febrile Illness

United States
Assisting Nature

Unknown

Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol

Pregnancy, Ovarian

Greece
Assisting Nature

Unknown

Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol

Pregnancy, Ovarian

Greece
Assisting Nature

Unknown

Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

Pregnancy, Ovarian

Greece
Anthera Pharmaceuticals

Completed

EASY: Extended Access to Sollpura Over Years

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States, Hungary, Israel, Poland, Spain, Czechia
Anthera Pharmaceuticals

Unknown

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States, Hungary, Israel, Lithuania, Poland, Spain, United Kingdom
Anthera Pharmaceuticals

Terminated

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Systemic Lupus Erythematosus

Georgia
Anthera Pharmaceuticals

Completed

CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus (CHABLIS-SC1)

Systemic Lupus Erythematosus

Georgia, Belarus, Brazil, Colombia, Guatemala, Hong Kong, India, Korea, Republic of, Malaysia, Mexico, Philippines, Russian Federation, Singapore, Sri Lanka, Taiwan, Thailand
Patara Pharma

Completed

Treatment of Refractory Chronic Cough With PA101

Refractory Chronic Cough

Netherlands, United Kingdom

Clinical Trials Sponsored by Natera, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations